Canadian Journal of Urology - Volume 21 Supplement 1 - April 2014 - page 11

TheCanadian Journal ofUrology is indexedandabstracted in IndexMedicus/Medline,CurrentContents/ClinicalMedicine,
ScienceCitation IndexExpanded (SciSearch) and Journal CitationReports/ScienceEdition.
Visit ourwebsite:www.canjurol.com
A9
©TheCanadian Journal ofUrology™: International Supplement, April 2014
INTRODUCTION – LeonardG. Gomella,Daniel P. Petrylak, BobbyShayegan..................................................................1
Currentmanagement of advanced and castration resistant prostate cancer
The changing landscapeof advanced and castration resistant prostate cancer:
latest science and reviseddefinitions.................................................................................................................................7
DeryaTilki, ChristopherP. Evans
Traditional androgen ablation approaches to advancedprostate cancer:
new insights...........................................................................................................................................................................14
KyleO. Rove, E.DavidCrawford
Utilityof LHRH antagonists for advancedprostate cancer.........................................................................................22
JuddW.Moul
Intermittent androgendeprivation therapy forprostate cancer:
translating randomized controlled trials into clinical practice...................................................................................28
ShawnDason, ChristopherBrianAllard, JingGennieWang, JenHoogenes, BobbyShayegan
Secondaryhormonalmanipulation in castration resistant prostate cancer..............................................................37
SohaibAl-Asaaed, EricWinquist
Imaging approacheswith advancedprostate cancer: techniques and timing..........................................................42
DavidLeung, SaravananKrishnamoorthy, Lawrence Schwartz, ChaitanyaDivgi
Practical guide to immunotherapy in castration resistant prostate cancer:
theuseof sipuleucel-T immunotherapy ..........................................................................................................................48
LeonardG. Gomella, FranciscoGelpi-Hammerschmidt, ChandanKundavram
Contents
Volume 21, Supplement 1,April 2014 INTERNATIONAL SUPPLEMENT
™
THE CANADIAN JOURNAL OF
UROLOGY